1. Anon (2001) ICH S7A: Safety pharmacology studies for human pharmaceuticals Fed Reg 66:36791 − 36792.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm074959.pdf
2. Anon (2010) ICH S9: Nonclinical evaluation for anticancer pharmaceuticals guidance Fed Reg 75:10487–10488.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm085389.pdf
3. Authier S, Tanguay JF, Fournier S, Gauvin D, Legaspi M, Chaurand F, Breault C, Troncy E (2008) Conscious and anesthetized non-human primate safety pharmacology models: hemodynamic sensitivity comparison. J Pharmacol Toxicol Methods 58:94–98
4. Biaggioni I, Zygmunt D, Haile V, Robertson D (1990) Pressor effect of inhaled ergotamine in orthostatic hypotension. Am J Cardiol 65:89–92
5. Borysenko M, Beringer T (1984) Functional histology. Little, Brown and Company Inc., Boston, pp 195–208